A model of erythropoiesis in adults with sufficient iron availability

Journal of Mathematical Biology

Volumn 66, Issue 6, 2013, Pages 1209-1240

  Fuertinger, Doris H ^a   Kappel, Franz ^a   Thijssen, Stephan ^b   Levin, Nathan W ^b   Kotanko, Peter ^b  

^a UNIVERSITY OF GRAZ   (Austria)

^b RENAL RESEARCH INSTITUTE   (United States)

Author keywords

Erythropoiesis; Neocytolysis; Structured population models

Indexed keywords

ANTIANEMIC AGENT; EPO PROTEIN, HUMAN; ERYTHROPOIETIN; IRON;

ACCLIMATIZATION; ADULT; ALGORITHM; ALTITUDE; ANEMIA; ARTICLE; BIOLOGICAL MODEL; BLOOD; BLOOD DONOR; CHRONIC KIDNEY FAILURE; DRUG EFFECT; ERYTHROPOIESIS; HOMEOSTASIS; HUMAN; MATHEMATICAL PHENOMENA; PHYSIOLOGY;

ACCLIMATIZATION; ADULT; ALGORITHMS; ALTITUDE; ANEMIA; BLOOD DONORS; ERYTHROPOIESIS; ERYTHROPOIETIN; HEMATINICS; HOMEOSTASIS; HUMANS; IRON; KIDNEY FAILURE, CHRONIC; MATHEMATICAL CONCEPTS; MODELS, BIOLOGICAL;

EID: 84876094304     PISSN: 03036812     EISSN: 14321416     Source Type: Journal    
DOI: 10.1007/s00285-012-0530-0     Document Type: Article

References (44)

1. Ackleh AS, Banks HT, Deng K (2002) A finite difference approximation for a coupled system of nonlinear size-structured population. Nonlinear Anal 50: 727-748.
2. Ackleh AS, Deng K, Ito K, Thibodeaux J (2006) A structured erythropoiesis model with nonlinear cell maturation velocity and hormone decay rate. Math Biosci 204: 21-48.
3. Adimy M, Crauste F, Ruan S (2006) Modelling hematopoiesis mediated by growth factors with applications to periodic hematological diseases. Bull Math Biol 68: 2321-2351.
4. Alfrey CP, Fishbane S (2007) Implications of neocytolysis for optimal management of anaemia in chronic kidney disease. Nephron Clin Pract 106: 149-156.
5. Alfrey CP, Udden MM, Leach-Huntoon C, Driscoll T, Pickett MH (1996) Control of red blood cell mass in spaceflight. J Appl Physiol 81: 98-104.
6. Banks HT, Cole CE, Schlosser PM, Tran HT (2004) Modelling and optimal regulation of erythropoiesis subject to benzene intoxication. Math Biosci Eng 1: 15-48.
7. Barosi G, Cazzola M, Berzuini C, Quaglini S, Stefanelli M (1985) Classification of anemia on the basis of ferrokinetic parameters. Br J Haematol 61: 357-370.
8. Belair J, Mackey MC, Mahaffy JM (1995) Age-structured and two-delay models for erythropoiesis. Math Biosci 128: 317-346.
9. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA (1998) The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. New Engl J Med 339: 584-590.
10. Besarab A, Reyes CM, Hornberger J (2002) Meta-analysis of subcutaneous versus intravenous epoetin in maintenance treatment of anemia in hemodialysis patients. J Kidney Dis 40: 439-446.
11. Chang CC, Chen Y, Modi K, Awar OG, Alfrey CP, Rice L (2009) Changes of red blood cell surface markers in a blood doping model of neocytolysis. J Investig Med 57: 650-654.
12. Cheung W, Minton N, Gunawardena K (2001) Pharmocokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly. Eur J Clin Pharmacol 57: 411-418.
13. Crauste F, Pujo-Menjouet L, Genieys S, Molina C, Gandrillon O (2008) Adding self-renewal in committed erythroid progenitors improves the biological relevance of a mathematical model of erythropoiesis. J Theor Biol 250: 322-338.
14. Crichton R (2009) Iron metabolism: from molecular mechanisms to clinical consequences, 3rd edn. Wiley, New York.
15. Feagan BG, Wong CJ, Kirkley A, Johnston DW, Smith FC, Whitsitt P, Wheeler S, Lau CY (2000) Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. Ann Intern Med 133: 845-854.
16. Finch CA (1982) Erythropoiesis, erythropoietin, and iron. Blood The Journal of American Society of Hematology 60(6): 1241-1246.
17. Finch S, Haskins D, Finch CA (1950) Iron metabolism. Hematopoiesis following phlebotomy. Iron as a limiting factor. J Clin Investig 29: 1078-1086.
18. Fleming MD (2008) The regulation of hepcidin and its effects on systemic and cellular iron metabolism. Hematology Journal of American Society of Hematology 2008(1): 151-158.
19. Fowler WM, Barner AP (1942) Rate of hemoglobin regeneration in blood donors. J Am Med Assoc 118(6): 421-427.
20. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New Engl J Med 351: 1296-1305.
21. Goodnough LT (2002) The role of iron in erythropoiesis in the absence and presence of erythropoietin therapy. Nephrol Dial Transplant 17: 14-18.
22. Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber DA, Means RTJ (2009) Wintrobe's clinical hematology, vol 1, 12th edn. Lippincott Williams and Wilkins, Philadelphia.
23. Ito K, Kappel F (2002) Evolution equations and approximations. World Scientific, Singapore.
24. Jandl JH (1987) Blood. Textbook of Hematology. Little, Brown and Company, Boston.
25. Jaspan D (2007) Erythropoietic therapy: cost efficiency and reimbursement. Am J Health-System Pharm, 64(16 Suppl 11): 19-29. doi: 10. 2146/ajhp070246.
26. Kappel F, Zhang K (1993) Approximation of linear age-structured population models using Legendre polynomials. J Math Anal Appl 180: 518-549.
27. Kotanko P, Kuhlmann MK, Levin NW (2007) Hemodialysis: technology, adequacy, and outcomes. In: Feehally J, Floege J, Johnson JR (eds) Comprehensive clinical nephrology, chap 83. Mosby Elsevier, Philadelphia, pp 953-966.
28. Lichtman, MA, Beutler, E, Kipps, TJ, Seligsohn, U, Kaushansky, K, Prchal, JT (eds) (2005) Williams hematology, 7th edn. McGraw-Hill, New York.
29. Loeffler M, Pantel K, Wulff H, Wichmann HE (1989) A mathematical model of erythropoiesis in mice and rats. Part 1. Structure of the model. Cell Tissue Kinetics 22: 13-30.
30. Mahaffy JM, Belair J, Mackey MC (1998) Hematopoietic model with moving boundary condition and state dependent delay: applications in erythropoiesis. J Theor Biol 190: 135-146.
31. Mahaffy JM, Polk SW, Roeder RK (1999) An age-structured model for erythropoiesis following a phlebotomy. Tech. Rep. CRM-2598, Department of Mathematical Sciences, San Diego State University, San Diego, CA 92182-0314.
32. Pottgiesser T, Specker W, Umhau M, Dickhuth HH, Roecker K, Schumacher YO (2008) Recovery of hemoglobin mass after blood donation. Transfusion 48: 1390-1397.
33. Rice L, Alfrey CP (2005) The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations. Cell Physiol Biochem 15: 245-250.
34. Rice L, Alfrey CP, Driscoll T, Whitley CE, Hachey DL, Suki W (1999) Neocytolysis contributes to the anemia of renal disease. Am J Kidney Dis 33: 59-62.
35. Rice L, Ruiz W, Driscoll T, Whitley CE, Tapia R, Hachey DL, Conzales GF, Alfrey CP (2001) Neocytolysis on descent from altitude: a newly recognized mechanism for the control of red cell mass. Ann Intern Med 134: 652-656.
36. Roeder I (2006) Quantitative stem cell biology: computational studies in the hematopoietic system. Curr Opin Hematol 13: 222-228.
37. Roeder I, Loeffler M (2002) A novel dynamic model of hematopoietic stem cell organization based on the concept of within-tissue plasticity. Exp Hematol 30: 853-861.
38. Schaefer RM, Schaefer L (1998) Iron monitoring and supplementation: how do we achieve the best results. Nephrol Dial Transplant 13: 9-12.
39. Stefanelli M, Bentley DP, Cavill I, Roeser HP (1984) Quantitation of reticuloendothelial iron kinetics in humans. Am J Physiol 247: 842-849.
40. Strippoli GF, Craig JC, Manno C, Schena FP (2004) Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials. J Am Soc Nephrol 15: 3154-3165.
41. Udden MM, Driscoll TB, Pickett MH, Leach-Huntoon CS, Alfrey CP (1995) Decreased production of red blood cells in human subjects exposed to microgravity. J Lab Clin Med 125: 442-449.
42. Wichmann HE, Loeffler M, Pantel K, Wulff HH (1989) A mathematical model of erythropoiesis in mice and rats. Part 2. Stimulated erythropoiesis. Cell Tissue Kinetics 22: 31-49.
43. Wu H, Liu X, Jaenisch R, Lodish HF (1995) Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83(1): 59-67.
44. Wulff H, Wichmann HE, Pantel K, Loeffler M (1989) A mathematical model of erythropoiesis in mice and rats. Part 3: suppressed erythropoiesis. Cell Tissue Kinetics 22: 51-61.